Answers are grounded in this paper and cite their sources.
Strengthening regulatory systems for medicines in low-income and middle-income countries is critical to ensure fit for purpose, future-proofed and efficient regulatory systems that facilitate access to safe and effective medicines for patients; this holds true before, during and after the COVID-19 pandemic.
No takes yet. Share an insight, caveat, or question.
O’Brien et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: